scholarly journals Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

2015 ◽  
Vol 17 (31) ◽  
pp. 281-282
Author(s):  
T Brown ◽  
G Pilkington ◽  
A Bagust ◽  
A Boland ◽  
J Oyee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Economic Evaluation ◽  
Locally Advanced ◽  
Clinical Effectiveness ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Hazard Ratios ◽  
Line Chemotherapy

AbstractTable 96 has been removed as it includes incorrect hazard ratios caused by a reversal of the hazard ratio calculations. However, this does not impact on any of the clinical or economic results reported.

Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: A systematic review with meta-analysis

2009 ◽  
Vol 45 (4) ◽  
pp. 601-607 ◽  
Author(s):  
João Paulo da Silveira Nogueira Lima ◽  
Lucas Vieira dos Santos ◽  
Emma Chen Sasse ◽  
Andre Deeke Sasse
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Optimal Duration ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document